Anzon John

Background

About Anzon John

Navya Care leverages expertise in AI and NLP to validate oncology data for treatment recommendations, tumor staging, and biomarker identification. Contributed to structuring patient data from EHRs and clinical reports, ensuring compliance with oncology guidelines like NCCN and ICD-10. Collaborated with AI engineers to enhance NLP models for tumor staging and pharmacogenomics integration, supporting precision oncology initiatives. M.Sc. in Global Public Health (Technische Hochschule Deggendorf, 2025) with a Doctor of Pharmacy (Pharm.D) from Rajiv Gandhi University. Clinical Safety Scientist with 5+ years of experience in oncology data analysis, AI-enabled risk prediction, and pharmacovigilance. Skilled in explainable AI (XAI), NLP, and predictive analytics for cancer detection and risk assessment, with proven success in optimizing ML models to improve precision and clinical trust. Experienced in safety data evaluation, regulatory compliance (ICH, EU-GVP, HIPAA, GDPR), and cross-functional collaboration with oncologists, epidemiologists, and data scientists. Published researcher with contributions in oncology, cardiology, and rare neurological case studies. Dedicated to advancing healthcare informatics by delivering actionable insights that improve patient outcomes while upholding global regulatory and ethical standards.